Ultragenyx Pharmaceutical Inc. — DEF 14A Filings
13 DEF 14A filings on record
This page lists all DEF 14A filings submitted to the SEC by Ultragenyx Pharmaceutical Inc. (RARE), sorted by most recent first. Each row links to the full filing on EdgarLookup. Ultragenyx Pharmaceutical Inc. has filed 13 DEF 14A documents with the SEC since 2014. To view all SEC filings by Ultragenyx Pharmaceutical Inc., see the full filings list.
All
10-K
10-Q
10-Q/A
144
3
3/A
4
4/A
424B4
424B5
424B7
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
EFFECT
FWP
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-T
SC TO-T/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001308179-26-000174 | Mar 27, 2026 | May 14, 2026 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001308179-25-000296 | Mar 28, 2025 | May 15, 2025 |
| DEF 14A | ULTRAGENYX PHARMACEUTICAL INC. - DEF 14A | 0001308179-24-000609 | Apr 26, 2024 | Jun 18, 2024 |
| DEF 14A | ULTRAGENYX PHARMACEUTICAL INC. - DEF 14A | 0001308179-23-000757 | Apr 24, 2023 | — |
| DEF 14A | ULTRAGENYX PHARMACEUTICAL INC. - DEF 14A | 0001308179-22-000294 | Apr 28, 2022 | Jun 24, 2022 |
| DEF 14A | ULTRAGENYX PHARMACEUTICAL INC. - DEF 14A | 0001308179-21-000276 | Apr 29, 2021 | Jun 24, 2021 |
| DEF 14A | DEF 14A | 0001193125-20-126182 | Apr 29, 2020 | Jun 26, 2020 |
| DEF 14A | DEF 14A | 0001193125-19-112719 | Apr 22, 2019 | Jun 11, 2019 |
| DEF 14A | DEF 14A | 0001193125-18-136529 | Apr 27, 2018 | Jun 19, 2018 |
| DEF 14A | DEF 14A | 0001193125-17-148058 | Apr 28, 2017 | Jun 22, 2017 |
| DEF 14A | DEF 14A | 0001193125-16-544873 | Apr 18, 2016 | Jun 9, 2016 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001193125-15-152921 | Apr 28, 2015 | Jun 18, 2015 |
| DEF 14A | DEF 14A | 0001193125-14-211538 | May 23, 2014 | Jul 10, 2014 |